Zensar Technologies Ltd (ZENSARTECH) Q1 FY27 Results Analysis: EBITDA Margin Compresses 163 bps, CIS Segment Surges 16.8%
Zensar Technologies Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,508.30 Cr (+8.90% YoY) and PAT growth of +1.00% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 29, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 1,508.30 Cr (+8.90% YoY) |
| PAT (Q1) | Rs. 183.80 Cr (+1.00% YoY) |
| EBITDA margin | 14.65% (-56 bps YoY) |
| EPS (Q1) | Rs. 8.11 (+1.20% YoY) |
| Market cap | Rs. 12,190.40 Cr |
| CMP | Rs. 535.45 |
Quarter Snapshot
Revenue grew 4% QoQ and met the 'no degrowth' guidance, but EBITDA margin compressed 163 bps QoQ to 14.65% as subcontracting and other costs surged. Subsidiary PAT collapsed to negligible, leaving PAT flat YoY. The CIS segment continues to drive growth at 16.8% YoY, while the mega deal ramp and cost normalisation in H2 are key catalysts.
Key Investment Insights
Key Positives
- Revenue grew 4.0% QoQ to Rs.1,508.3 Cr, confirming management's 'no degrowth' guidance for Q1.
- CIS segment revenue grew 16.8% YoY, outpacing the company average and demonstrating structural demand in cloud and security.
- Unearned revenue nearly tripled QoQ to Rs.68.5 Cr, indicating strong advance collections.
- Employee cost as % of revenue improved 329 bps QoQ to 61.15%.
Risk Factors
- PAT was nearly flat YoY (+1.0%) despite 8.9% revenue growth, showing margin pressure.
- EBITDA margin fell 163 bps QoQ to 14.65% (lower end of the 14-16% band), partly due to cost surges.
- Subcontracting costs jumped 33.8% QoQ and 32.0% YoY to 16.23% of revenue.
- Subsidiary PAT contribution collapsed to just Rs.0.3 Cr from Rs.10.2 Cr YoY, driving the earnings lag.
- DAS segment EBIT margin at 14.86% is the lowest in available quarters, dropping 134 bps QoQ.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.